Yu Baofa
Chinese oncologist and cancer pioneer, clinician, and researcher
About Yu Baofa
Born 1958. Yu Baofa is a Chinese physician and oncologist.
Yu Baofa (; born in 1958) is a Chinese oncologist and researcher in intratumoral cancer therapy and drug development. He is the Founder, CEO and Chairman of Baofa Cancer Hospital Network China in Jinan, Beijing and Dongping. He also developed Ultra Minimum Incision Personalized Intra-Tumoral Chemo-Immuno (UMIPIC) Therapy.
Early life and education Yu was born in 1958 in Jinan, Shandong, China. During his childhood, the local doctors he saw in his village inspired him to become a physician in the future. He was educated in Binzhou Medical College. Four years later, he graduated and landed a job in the Shandong Tumor Research Institute and transferred to the China Academy of Medical Sciences for further studies in cancer.
His hospitals utilize various cancer treatments including surgery, radiotherapy, biological therapy, UMIPIC, as well as traditional Chinese medical treatments. 2005- First overseas Chinese "Outstanding Entrepreneurship Award"
Patents
Publications
Don’t just read it —
keep it.
Full-length biographies made to live with: read them, listen on the way to work, watch them tonight.
- E-book
- Audio
- Video
Instant download · yours to keep · every purchase keeps this site free
Important facts
Contemporaries
People whose lives overlapped Yu Baofa's
Frequently asked questions
Who is Yu Baofa?
Chinese oncologist and cancer pioneer, clinician, and researcher
When was Yu Baofa born?
Yu Baofa was born in 1958 in Jinan.
What is Yu Baofa's occupation?
Yu Baofa is a physician and oncologist.
What nationality is Yu Baofa?
Yu Baofa is Chinese.
Sources & further reading
Cite this page
APA: Biography.guide. (2026). Yu Baofa. https://biography.guide/yu-baofa/
MLA: "Yu Baofa." Biography.guide, https://biography.guide/yu-baofa/.
Chicago: "Yu Baofa." Biography.guide. https://biography.guide/yu-baofa/.
Data last updated: 2026-09-20 · Spot an error? Report a correction.
Page generated 2026-09-27 04:58 UTC